Recurrent Clostridium difficile disease following ciprofloxacin use.
Bauwens
J E
JE
Western Washington Medical Group, Everett, WA, USA.
McFarland
L V
LV
Melcher
S A
SA
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002939:Ciprofloxacin / Q000627:therapeutic use*; D016360:Clostridioides difficile / Q000302:isolation & purification*; D003113:Colonoscopy; D003967:Diarrhea / Q000382:microbiology; D004761:Enterocolitis, Pseudomembranous / Q000139:chemically induced* / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D005260:Female; D006801:Humans; D008875:Middle Aged; D012008:Recurrence
D000890:Anti-Infective Agents; D002939:Ciprofloxacin